Fixes QIP closure date and issue price
The QIP Committee of Nath Bio-Genes (India) on 25th January 2018 has authorized the closure of the QIP on 25 January 2018, and fixed the issue price of Rs 455 after giving discount of 2.92% on the floor price of Rs 468.69 per equity share for the equity shares to be issued and allotted to eligible Qualified Institutional Buyers in the QIP, approved the Placement Document dated 25th January 2018, and approved the issue of Confirmation Allocation Note for the allocation of 30,00,000 Equity Shares to the eligible QIB's.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
